FR2187298B1 - - Google Patents

Info

Publication number
FR2187298B1
FR2187298B1 FR7309052A FR7309052A FR2187298B1 FR 2187298 B1 FR2187298 B1 FR 2187298B1 FR 7309052 A FR7309052 A FR 7309052A FR 7309052 A FR7309052 A FR 7309052A FR 2187298 B1 FR2187298 B1 FR 2187298B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7309052A
Other versions
FR2187298A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2187298A1 publication Critical patent/FR2187298A1/fr
Application granted granted Critical
Publication of FR2187298B1 publication Critical patent/FR2187298B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7309052A 1972-06-14 1973-03-14 Expired FR2187298B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins

Publications (2)

Publication Number Publication Date
FR2187298A1 FR2187298A1 (fr) 1974-01-18
FR2187298B1 true FR2187298B1 (fr) 1976-12-03

Family

ID=26949532

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7309052A Expired FR2187298B1 (fr) 1972-06-14 1973-03-14
FR7316936A Expired FR2187299B1 (fr) 1972-06-14 1973-05-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7316936A Expired FR2187299B1 (fr) 1972-06-14 1973-05-10

Country Status (20)

Country Link
JP (2) JPS5518716B2 (fr)
AR (1) AR197237A1 (fr)
AT (1) AT324560B (fr)
AU (1) AU464107B2 (fr)
CA (2) CA1076560A (fr)
CH (2) CH586709A5 (fr)
DD (1) DD105238A5 (fr)
DE (1) DE2316867C2 (fr)
DK (1) DK142913B (fr)
ES (2) ES412207A1 (fr)
FI (1) FI56843C (fr)
FR (2) FR2187298B1 (fr)
GB (2) GB1363833A (fr)
HU (1) HU168689B (fr)
IE (2) IE37409B1 (fr)
IL (1) IL42126A (fr)
NL (2) NL7302817A (fr)
PH (1) PH9941A (fr)
PL (1) PL91074B1 (fr)
SE (2) SE416472B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR780000197B1 (en) * 1972-12-26 1978-05-26 Bristol Myers Co Method for preparing antibacterial agent
JPS5953275B2 (ja) * 1973-01-31 1984-12-24 ブリストル マイヤ−ズ カンパニ− 抗菌剤の製法
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (fr) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDOCEPHALOSPORINES
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
NL162387C (nl) * 1977-09-06 1980-05-16 Gist Brocades Nv Werkwijze voor het bereiden van 6-(d-alpha-amino-p- -hydroxyfenylacetamido)penicillanzuur.
JPS6010226U (ja) * 1983-06-30 1985-01-24 松下電工株式会社 昇降装置
JPS6182606A (ja) * 1984-09-29 1986-04-26 東芝ライテック株式会社 昇降装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA698494B (en) * 1969-02-26 1971-07-28 Lilly Co Eli Sulfur-containing cephalosporing antibiotics
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
FI56843C (fi) 1980-04-10
DD105238A5 (fr) 1974-04-12
DE2316866A1 (de) 1974-01-03
ES412207A1 (es) 1976-01-01
IE37409B1 (en) 1977-07-20
CH589093A5 (fr) 1977-06-30
DE2316867A1 (de) 1974-01-03
AT324560B (de) 1975-09-10
SE404190B (sv) 1978-09-25
FR2187298A1 (fr) 1974-01-18
IE37499B1 (en) 1977-08-03
DE2316866B2 (de) 1976-10-07
PL91074B1 (en) 1977-02-28
IE37409L (en) 1973-12-14
NL7305206A (fr) 1973-12-18
DE2316867C2 (de) 1982-05-19
JPS4954393A (fr) 1974-05-27
AU5234573A (en) 1974-08-22
IE37499L (en) 1973-12-14
IL42126A0 (en) 1973-06-29
FR2187299B1 (fr) 1976-12-03
CA999293A (en) 1976-11-02
JPS5953274B2 (ja) 1984-12-24
DK142913B (da) 1981-02-23
ES413501A1 (es) 1976-07-16
CH586709A5 (fr) 1977-04-15
JPS5518716B2 (fr) 1980-05-21
CA1076560A (fr) 1980-04-29
HU168689B (fr) 1976-06-28
GB1358027A (en) 1974-06-26
JPS4931689A (fr) 1974-03-22
AU464107B2 (en) 1975-08-14
AR197237A1 (es) 1974-03-22
FI56843B (fi) 1979-12-31
FR2187299A1 (fr) 1974-01-18
SE416472B (sv) 1981-01-05
GB1363833A (en) 1974-08-21
NL7302817A (fr) 1973-12-18
PH9941A (en) 1976-06-14
DK142913C (fr) 1981-09-28
IL42126A (en) 1975-12-31

Similar Documents

Publication Publication Date Title
HU168026B (fr)
FR2187299B1 (fr)
JPS4948710A (fr)
FR2187305A1 (fr)
FR2168248B1 (fr)
JPS4926119U (fr)
FR2207585A5 (fr)
CS171273B2 (fr)
JPS5244885Y2 (fr)
CS178128B2 (fr)
JPS5438727B2 (fr)
JPS491387Y1 (fr)
JPS4977925U (fr)
CS155577B1 (fr)
CS157576B1 (fr)
JPS4934623U (fr)
CS178096B2 (fr)
CS154508B1 (fr)
CS156806B1 (fr)
CS170846B1 (fr)
CS168902B3 (fr)
CS165090B1 (fr)
CS161029B1 (fr)
CS160894B1 (fr)
CS154826B1 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name